Genetically engineered cartilage delivers anti-inflammatory drug in response to knee activity – News-Medical.Net

Working to develop new treatments for osteoarthritis, researchers at Washington University School of Medicine in St. Louis have genetically engineered cartilage to deliver an anti-inflammatory drug in response to activity similar to the bending of a knee or other motions that put stress on joints.
Among the early symptoms of osteoarthritis is pain in response to such movements -; motions that involve the so-called mechanical loading of a joint. Joint pain that accompanies bending or lifting can…

Click here to view the original article.